Clinical Development Organization, a division of Lilly Research Laboratories, partners with colleagues in Research, Oncology, Biomedicines, and Diabetes to effectively and efficiently design, plan, and execute clinical trials across all phases of research. Uniting authorities in clinical development and design, laboratory and data sciences
M.Pharm Pharmacognosy, M.Pharm Ayurveda, M.Sc Medicinal Plants, Masters Degree in Botany from a recognized University/Institution. 03 years Research / Teaching Experience after PG Degree.
Minimum Educational Qualification Only candidates possessing the minimum qualification prescribed in the University Grants Commission, PCI Regulations, and the revised statutes of Lucknow University will be allowed to appear in the interview.
Completed applications are invited for the following posts on a fully temporary basis on contract basis to fill the vacant posts on a lump sum basis in Primary Health Centers / Vellore Corporation
A Diploma in Pharmacy / Bachelor of Pharmacy. Must have registered with Pharmacy Council Tamil Nadu and must keep the registration alive by renewing it regularly every year.
Indian citizens and People of Indian origin with PIO status having Ph.D. degree in science, mathematics, engineering, pharmacy, medicine and agriculture related subjects from any recognized university in the world.
Candidates having Ph.D Degree in Molecular Biology, Biochemistry, Plant Science, Life Sciences, Biotechnology or equivalent from recognised University.
Masters Degree in Molecular Biology / Biochemistry / Plant Science / Life Sciences / Biotechnology or Bachelor degree in Engineering or Technology or Medicine at NIPGR, Delhi
Masters in Biotechnology, Bioinformatics, Computational biology, Data Science. Proven experience in front-end and/or back-end development of web portals or similar applications. Institute of Genomics & Integrative Biology
Vanda Pharmaceuticals Inc. (Vanda) announced that it secured a landmark victory over the U.S. Food and Drug Administration (FDA) in its longstanding dispute with the agency regarding the approvability of HETLIOZ® (tasimelteon) to treat jet lag disorder